The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is RCC truly radioresistant? Local control rates of metastatic renal cell carcinoma (RCC) to the lung using stereotactic radiotherapy (SBRT).
 
Basel M Altoos
No Relationships to Disclose
 
Arya Amini
No Relationships to Disclose
 
Maria Teresa Bourlon
No Relationships to Disclose
 
Christine M. Fisher
No Relationships to Disclose
 
Edward Bedrick
No Relationships to Disclose
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Honoraria - BN ImmunoTherapeutics; GTx
Consulting or Advisory Role - GTX
Research Funding - Amgen; Bavarian Nordic; Bristol-Myers Squibb; Cougar Biotechnology; Dendreon; Exelixis; GlaxoSmithKline; GlaxoSmithKline; GTx; Janssen Oncology; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents in which I am an inventor. These are related to bladder cancer treatment of early stage disease.
Travel, Accommodations, Expenses - Bavarian Nordic; GTx
Other Relationship - Aurora Oncology
 
Elaine Tat Lam
No Relationships to Disclose
 
Elizabeth Riley Kessler
No Relationships to Disclose
 
Brian D. Kavanagh
No Relationships to Disclose
 
Sana D Karam
No Relationships to Disclose